Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768543 · ClinicalTrials.gov registry record
Stimulation Therapy for Apnea: Reporting Thoughts
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 26
- Enrollment target
NCT04768543: Completed study, sponsored by University of Pittsburgh.
NCT04768543 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04768543 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.
Primary Outcome
individual qualitative interview via telephone
Interventions
- DEVICE Upper airway stimulation (Inspire Medical Systems, Inc.)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-03-02 |
| Est. Completion | 2021-05-01 |
What the finished NCT04768543 record still lists
NCT04768543 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Upper airway stimulation (Inspire Medical Systems, Inc.) is the first listed.
NCT04768543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04768543 about?
NCT04768543 is a clinical study titled "Stimulation Therapy for Apnea: Reporting Thoughts". Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy...
What is the current status of trial NCT04768543?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2020-03-02. Estimated completion is 2021-05-01.
What interventions are being tested in trial NCT04768543?
The interventions under investigation include: Upper airway stimulation (Inspire Medical Systems, Inc.) (DEVICE).
Who is sponsoring clinical trial NCT04768543?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI